<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2018-19-85-88</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-2752</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Онкоурология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Oncourology</subject></subj-group></article-categories><title-group><article-title>Цитотоксическая терапия рака предстательной железы</article-title><trans-title-group xml:lang="en"><trans-title>Cytotoxic therapy for prostate cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Русаков</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Rusakov</surname><given-names>I. G.</given-names></name></name-alternatives></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мишугин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mishugin</surname><given-names>S. V.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2018</year></pub-date><volume>0</volume><issue>19</issue><fpage>85</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Русаков И.Г., Мишугин С.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Русаков И.Г., Мишугин С.В.</copyright-holder><copyright-holder xml:lang="en">Rusakov I.G., Mishugin S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/2752">https://www.med-sovet.pro/jour/article/view/2752</self-uri><abstract><p>Интервью с вице-президентом Российского общества онкоурологов (РООУ), врачом-онкологом Московской городской клинической больницы № 57, доктором медицинских наук, профессором Игорем Георгиевичем РУСАКОВЫМ и заведующим отделением онкоурологии ГБУЗ «ГКБ им. Д.Д. Плетнева», кандидатом медицинских наук Сергеем Владимировичем МИШУГИНЫМ.</p></abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
